(Q28346517)

English

Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment

scientific article

In more languages

Statements

scholarly article

0 references

Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment (English)

0 references

0 references

0 references

arterial hypertension

1 reference

based on heuristic

inferred from title

primary pulmonary hypertension

1 reference

based on heuristic

inferred from title

author name string

V Petkov

1

0 references

R Ziesche

2

0 references

W Mosgoeller

3

0 references

P Schenk

4

0 references

K Vonbank

5

0 references

L Stiebellehner

6

0 references

M Raderer

7

0 references

C Brunner

8

0 references

M Kneussl

9

0 references

L H Block

10

0 references

language of work or name

0 references

publication date

September 2001

0 references

0 references

56

0 references

9

0 references

734-6

0 references

Treatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746148

29 September 2017

Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746148

29 September 2017

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746148

29 September 2017

Primary pulmonary hypertension. A national prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746148

29 September 2017

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746148

29 September 2017

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746148

2 June 2018

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746148

2 June 2018

Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11514696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11514696

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/THORAX.56.9.734

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28346517&oldid=1624415206"